A germline JAK2 exon12 mutation and a late somatic CALR mutation in a patient with essential thrombocythemia

Overview of attention for article published in Frontiers in oncology, January 2024

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Good Attention Score compared to outputs of the same age and source (76th percentile)

Mentioned by

twitter: 2 X users

Readers on

mendeley: 2 Mendeley

Summary X

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 6,608 followers.

RT @FrontOncology: New research: A germline JAK2 exon12 mutation and a late somatic CALR mutation in a patient with essential thrombocythem…

06 Jan 2024

Reply Repost Favourite

New research: A germline JAK2 exon12 mutation and a late somatic CALR mutation in a patient with essential thrombocythemia: Background It has been discovered that Janus kinase 2 (JAK2) exon12 mutations lead to the polycythemia vera (PV)… https://t.co/gvBx

04 Jan 2024

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.